This trial is testing different ways of using a rectal douche before and after simulated receptive anal intercourse, to see how well it protects against HIV acquisition.
1 Primary · 1 Secondary · Reporting Duration: Approximately 6 months from the time of enrollment
6 Total Participants · 1 Treatment Group
Primary Treatment: Tenofovir Douche · No Placebo Group · Phase 1
Participation is compensated
You will be compensated for participating in this trial.
Age 18+ · Male Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: